Skip to content
healthcare.dev

Symvess

NDC 83564-110, ACELLULAR TISSUE ENGINEERED VESSEL, implant, from Humacyte Global, Inc..

Product NDC
83564-110
Status
Listed
Labeler
Humacyte Global, Inc.
Dosage form
IMPLANT
Route
INTRAVASCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125812
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83564-110 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACELLULAR TISSUE ENGINEERED VESSEL420 mm/1
Package NDCNDC-11Package
83564-110-00835640110001 BOX in 1 BAG (83564-110-00) / 1 IMPLANT in 1 BOX (83564-110-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/15e9e29f-5aa6-4fc6-b0fe-a48cd1473418

Use it

Look up 83564-110 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83564-110 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83564-110. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.